Department of Pharmacotherapeutics, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8102, Japan.
Department of Medicine, University of California, San Diego, MC0063, 9500 Gilman Drive, La Jolla, San Diego, CA, 92093, USA.
J Gastroenterol. 2018 Jun;53(6):691-700. doi: 10.1007/s00535-017-1400-8. Epub 2017 Oct 26.
Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple functions in the gut, such as to regulate microbiota composition, to protect intestinal epithelium from pathogenic microorganisms, and to help for immune-system development. The liver is the front-line organ that receives gut-derived products through the portal vein, implying that the liver could be severely affected by a disrupted intestinal homeostasis. Indeed, some liver diseases like alcoholic liver disease are associated with an altered composition of gut microbiota and increased blood endotoxin levels. Therefore, deficiency of SIgA function appears as a significant factor for the pathogenesis of liver diseases associated with altered gut microbiome. In this review, we describe SIgA functions on the gut microbiome and discuss the role of IgA for liver diseases, especially alcoholic liver disease and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
免疫球蛋白 A(IgA)是肠道中的主要免疫球蛋白类型,在维持肠道内环境稳定方面发挥作用。分泌型 IgA(SIgA)在肠道中有多种功能,例如调节微生物群落组成,保护肠道上皮免受病原微生物侵害,并有助于免疫系统发育。肝脏是通过门静脉接收肠道来源产物的一线器官,这意味着肝脏可能会受到肠道内环境破坏的严重影响。事实上,一些肝病,如酒精性肝病,与肠道微生物群落组成改变和血液内毒素水平升高有关。因此,SIgA 功能缺陷似乎是与肠道微生物群改变相关的肝病发病机制中的一个重要因素。在这篇综述中,我们描述了 SIgA 在肠道微生物群中的功能,并讨论了 IgA 在肝病,特别是酒精性肝病和非酒精性脂肪性肝病/非酒精性肝炎中的作用。